Imiquimod chemoprophylaxis for field cancerization in Xeroderma Pigmentosum patients

Published: 1 November 2021| Version 2 | DOI: 10.17632/g2j8nmxys6.2
Contributor:
Lilian Rocha

Description

A prospective study to examine topical imiquimod as chemoprophylaxis in Xeroderma Pigmentosum patients describing clinical evolution during 2 years of follow up.

Files

Steps to reproduce

This is a supplementary data to JAAD submission.

Institutions

Universidade de Sao Paulo Hospital das Clinicas

Categories

Dermatology

License